SlpA as a tool for recombinant protein and enzyme technology
    12.
    发明授权
    SlpA as a tool for recombinant protein and enzyme technology 有权
    SlpA作为重组蛋白和酶技术的工具

    公开(公告)号:US08790659B2

    公开(公告)日:2014-07-29

    申请号:US13569353

    申请日:2012-08-08

    IPC分类号: A61K39/245

    摘要: Disclosed are a recombinant DNA molecule encoding a fusion protein comprising a SlpA chaperone and a target polypeptide wherein human FK506 binding proteins (FKBPs) are excluded as target polypeptides, a corresponding expression vector encoding said fusion protein as well as host cells transformed with said expression vector. Also disclosed are a method for producing the fusion protein, a recombinantly produced fusion protein comprising a SlpA chaperone and a target polypeptide. A further aspect of the invention is the use of the recombinantly produced fusion protein, and a reagent kit containing a recombinantly produced fusion protein comprising a SlpA chaperone and a target polypeptide.

    摘要翻译: 公开了编码包含SlpA伴侣和靶多肽的融合蛋白的重组DNA分子,其中人FK506结合蛋白(FKBP)被排除为靶多肽,编码所述融合蛋白的相应表达载体以及用所述表达载体转化的宿主细胞 。 还公开了产生融合蛋白的方法,重组产生的包含SlpA伴侣和靶多肽的融合蛋白。 本发明的另一方面是使用重组产生的融合蛋白,以及含有重组产生的包含SlpA伴侣和靶多肽的融合蛋白的试剂盒。

    SLPA AS A TOOL FOR RECOMBINANT PROTEIN AND ENZYME TECHNOLOGY
    15.
    发明申请
    SLPA AS A TOOL FOR RECOMBINANT PROTEIN AND ENZYME TECHNOLOGY 有权
    SLPA作为重组蛋白和酶技术的工具

    公开(公告)号:US20120308994A1

    公开(公告)日:2012-12-06

    申请号:US13569353

    申请日:2012-08-08

    IPC分类号: G01N21/76 G01N33/569

    摘要: Disclosed are a recombinant DNA molecule encoding a fusion protein comprising a SlpA chaperone and a target polypeptide wherein human FK506 binding proteins (FKBPs) are excluded as target polypeptides, a corresponding expression vector encoding said fusion protein as well as host cells transformed with said expression vector. Also disclosed are a method for producing the fusion protein, a recombinantly produced fusion protein comprising a SlpA chaperone and a target polypeptide. A further aspect of the invention is the use of the recombinantly produced fusion protein, and a reagent kit containing a recombinantly produced fusion protein comprising a SlpA chaperone and a target polypeptide.

    摘要翻译: 公开了编码包含SlpA伴侣和靶多肽的融合蛋白的重组DNA分子,其中人FK506结合蛋白(FKBP)被排除为靶多肽,编码所述融合蛋白的相应表达载体以及用所述表达载体转化的宿主细胞 。 还公开了产生融合蛋白的方法,重组产生的包含SlpA伴侣和靶多肽的融合蛋白。 本发明的另一方面是使用重组产生的融合蛋白,以及含有重组产生的包含SlpA伴侣和靶多肽的融合蛋白的试剂盒。

    FUSION PROTEIN COMPRISING AN E. COLI CHAPERONE PROTEIN AND A HUMAN CHAPERONE PROTEIN
    16.
    发明申请
    FUSION PROTEIN COMPRISING AN E. COLI CHAPERONE PROTEIN AND A HUMAN CHAPERONE PROTEIN 有权
    包含大肠杆菌蛋白和蛋白质的融合蛋白

    公开(公告)号:US20110189754A1

    公开(公告)日:2011-08-04

    申请号:US13083903

    申请日:2011-04-11

    IPC分类号: C12N9/96 C07H21/04

    CPC分类号: C12N9/90 C07K2319/35

    摘要: The invention discloses the cloning, expression and uses of a chimeric fusion protein with superior chaperone and folding activities compared to the wild type chaperones. This invention relates to a chimeric fusion protein encoded by a recombinant DNA molecule containing nucleotide sequences coding for a polypeptide binding segment of a non-human chaperone protein and nucleotide sequences coding for an FK506 binding protein (FKBP) or an FK506-binding-protein-like domain (FKBP-like domain). In particular, this invention relates to a chimeric fusion protein encoded by a recombinant DNA molecule containing nucleotide sequences coding for a polypeptide binding segment of a non-human chaperone protein and nucleotide sequences coding for a human FKBP type peptidyl-prolyl-cis/trans isomerase (PPIase), methods of producing these chimeric fusion proteins and their uses as folding helpers in the production of other proteins and in the process of the production of vaccines or pharmaceuticals, and as folding helpers for performing immunoassays.

    摘要翻译: 本发明公开了与野生型伴侣相比,具有优异的伴侣和折叠活性的嵌合融合蛋白的克隆,表达和用途。 本发明涉及由含有编码非人伴侣蛋白多肽结合片段的核苷酸序列的重组DNA分子编码的嵌合融合蛋白和编码FK506结合蛋白(FKBP)或FK506-结合蛋白 - 像域(FKBP样域)。 特别地,本发明涉及由包含编码非人伴侣蛋白多肽结合片段的核苷酸序列的重组DNA分子编码的嵌合融合蛋白和编码人FKBP型肽基 - 脯氨酰 - 顺/反异构酶的核苷酸序列 (PPIase),生产这些嵌合融合蛋白的方法及其在生产其他蛋白质和疫苗或药物生产过程中作为折叠助剂的用途,以及用于进行免疫测定的折叠助剂。

    SlpA as a tool for recombinant protein and enzyme technology
    18.
    发明授权
    SlpA as a tool for recombinant protein and enzyme technology 有权
    SlpA作为重组蛋白和酶技术的工具

    公开(公告)号:US08263086B2

    公开(公告)日:2012-09-11

    申请号:US12436396

    申请日:2009-05-06

    IPC分类号: A61K39/245

    摘要: Disclosed are a recombinant DNA molecule encoding a fusion protein comprising a SlpA chaperone and a target polypeptide wherein human FK506 binding proteins (FKBPs) are excluded as target polypeptides, a corresponding expression vector encoding said fusion protein as well as host cells transformed with said expression vector. Also disclosed are a method for producing the fusion protein, a recombinantly produced fusion protein comprising a SlpA chaperone and a target polypeptide. A further aspect of the invention is the use of the recombinantly produced fusion protein, and a reagent kit containing a recombinantly produced fusion protein comprising a SlpA chaperone and a target polypeptide.

    摘要翻译: 公开了编码包含SlpA伴侣和靶多肽的融合蛋白的重组DNA分子,其中人FK506结合蛋白(FKBPs)被排除为靶多肽,编码所述融合蛋白的相应表达载体以及用所述表达载体转化的宿主细胞 。 还公开了产生融合蛋白的方法,重组产生的包含SlpA伴侣和靶多肽的融合蛋白。 本发明的另一方面是使用重组产生的融合蛋白,以及含有重组产生的包含SlpA伴侣和靶多肽的融合蛋白的试剂盒。

    Fusion protein comprising an Escherichia coli chaperone protein and a human chaperone protein
    19.
    发明授权
    Fusion protein comprising an Escherichia coli chaperone protein and a human chaperone protein 有权
    包含大肠杆菌伴侣蛋白和人伴侣蛋白的融合蛋白

    公开(公告)号:US08247206B2

    公开(公告)日:2012-08-21

    申请号:US13083903

    申请日:2011-04-11

    IPC分类号: C12N9/90 C07K14/00

    CPC分类号: C12N9/90 C07K2319/35

    摘要: The invention discloses the cloning, expression and uses of a chimeric fusion protein with superior chaperone and folding activities compared to the wild type chaperones. This invention relates to a chimeric fusion protein encoded by a recombinant DNA molecule containing nucleotide sequences coding for a polypeptide binding segment of a non-human chaperone protein and nucleotide sequences coding for an FK506 binding protein (FKBP) or an FK506-binding-protein-like domain (FKBP-like domain). In particular, this invention relates to a chimeric fusion protein encoded by a recombinant DNA molecule containing nucleotide sequences coding for a polypeptide binding segment of a non-human chaperone protein and nucleotide sequences coding for a human FKBP type peptidyl-prolyl-cis/trans isomerase (PPIase), methods of producing these chimeric fusion proteins and their uses as folding helpers in the production of other proteins and in the process of the production of vaccines or pharmaceuticals, and as folding helpers for performing immunoassays.

    摘要翻译: 本发明公开了与野生型伴侣相比,具有优异的伴侣和折叠活性的嵌合融合蛋白的克隆,表达和用途。 本发明涉及由含有编码非人伴侣蛋白多肽结合片段的核苷酸序列的重组DNA分子编码的嵌合融合蛋白和编码FK506结合蛋白(FKBP)或FK506-结合蛋白 - 像域(FKBP样域)。 特别地,本发明涉及由包含编码非人伴侣蛋白多肽结合片段的核苷酸序列的重组DNA分子编码的嵌合融合蛋白和编码人FKBP型肽基 - 脯氨酰 - 顺/反异构酶的核苷酸序列 (PPIase),生产这些嵌合融合蛋白的方法及其在生产其他蛋白质和疫苗或药物生产过程中作为折叠助剂的用途,以及用于进行免疫测定的折叠助剂。

    SlpA as a tool for recombinant protein and enzyme technology
    20.
    发明申请
    SlpA as a tool for recombinant protein and enzyme technology 有权
    SlpA作为重组蛋白和酶技术的工具

    公开(公告)号:US20090291892A1

    公开(公告)日:2009-11-26

    申请号:US12436396

    申请日:2009-05-06

    摘要: Disclosed are a recombinant DNA molecule encoding a fusion protein comprising a SlpA chaperone and a target polypeptide wherein human FK506 binding proteins (FKBPs) are excluded as target polypeptides, a corresponding expression vector encoding said fusion protein as well as host cells transformed with said expression vector. Also disclosed are a method for producing the fusion protein, a recombinantly produced fusion protein comprising a SlpA chaperone and a target polypeptide. A further aspect of the invention is the use of the recombinantly produced fusion protein, and a reagent kit containing a recombinantly produced fusion protein comprising a SlpA chaperone and a target polypeptide.

    摘要翻译: 公开了编码包含SlpA伴侣和靶多肽的融合蛋白的重组DNA分子,其中人FK506结合蛋白(FKBP)被排除为靶多肽,编码所述融合蛋白的相应表达载体以及用所述表达载体转化的宿主细胞 。 还公开了产生融合蛋白的方法,重组产生的包含SlpA伴侣和靶多肽的融合蛋白。 本发明的另一方面是使用重组产生的融合蛋白,以及含有重组产生的包含SlpA伴侣和靶多肽的融合蛋白的试剂盒。